Insider Selling: Billiontoone (NASDAQ:BLLN) SVP Sells $138,116.64 in Stock

Billiontoone, Inc. (NASDAQ:BLLN) SVP Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock in a transaction that occurred on Wednesday, September 9th. The stock was sold at an average price of $97.54, for a total transaction of $138,116.64. Following the completion of the sale, the senior vice president directly owned 25,051 shares in the company, valued at $2,443,474.54. This trade represents a 5.35% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Bosch John Roderick Ten also recently made the following trade(s):

• On Tuesday, August 25th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The shares were sold at an average price of $100.00, for a total value of $141,700.00.
• On Monday, August 10th, Bosch John Roderick Ten sold 1,417 shares of Billiontoone stock. The stock was sold at an average price of $92.86, for a total value of $131,582.62.
• On Monday, June 29th, Bosch John Roderick Ten sold 1,416 shares of Billiontoone stock. The shares were sold at an average price of $120.00, for a total value of $169,920.00.
• On Monday, June 15th, Bosch John Roderick Ten sold 2,832 shares of Billiontoone stock. The shares were sold at an average price of $101.47, for a total value of $287,363.04.

Billiontoone Price Performance

BLLN stock opened at $98.77 on Monday. The stock has a fifty day moving average of $111.64 and a 200-day moving average of $95.98. Billiontoone, Inc. has a fifty-two week low of $61.96 and a fifty-two week high of $150.44. The company has a market capitalization of $4.66 billion and a price-to-earnings ratio of 141.10. The company has a debt-to-equity ratio of 0.17, a quick ratio of 11.31 and a current ratio of 11.69.

Billiontoone (NASDAQ:BLLN) last announced its quarterly earnings data on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.15. The business had revenue of $109.45 million for the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. As a group, equities research analysts predict that Billiontoone, Inc. will post 0.83 earnings per share for the current year.

Analysts Set New Price Targets

BLLN has been the subject of several analyst reports. Zacks Research downgraded shares of Billiontoone from a “hold” rating to a “strong sell” rating in a report on Monday, August 31st. JPMorgan Chase & Co. lowered their target price on shares of Billiontoone from $145.00 to $130.00 and set an “overweight” rating on the stock in a report on Thursday, August 6th. Wall Street Zen downgraded Billiontoone from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Guggenheim assumed coverage on Billiontoone in a research report on Monday, June 29th. They issued a “buy” rating and a $125.00 price target for the company. Finally, Canaccord Genuity Group assumed coverage on Billiontoone in a research note on Wednesday, September 2nd. They set a “buy” rating and a $120.00 price objective on the stock. Seven analysts have rated the stock with a Buy rating, two have given a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $125.88.

Institutional Trading of Billiontoone

A number of hedge funds and other institutional investors have recently bought and sold shares of the company. UBS Group AG purchased a new stake in Billiontoone in the 4th quarter worth approximately $2,586,000. Nano Cap New Millennium Growth Fund L P purchased a new position in Billiontoone during the fourth quarter worth about $82,000. Geode Capital Management LLC bought a new position in Billiontoone in the 4th quarter worth about $6,716,000. Seven Grand Managers LLC purchased a new stake in shares of Billiontoone in the 4th quarter valued at about $2,046,000. Finally, Norges Bank purchased a new stake in shares of Billiontoone in the 4th quarter valued at about $818,000.

Billiontoone Company Profile

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company’s technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company’s primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.